Living Cell Technologies Ltd. (AU:1AI) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Algorae Pharmaceuticals has successfully launched its AI platform, AlgoraeOS, which uses advanced neural networks to predict drug target synergies. In preclinical studies, their AI-116 drug candidate for dementia showed promising results, surpassing existing treatments. The company is also advancing trials for AI-168, targeting cardiovascular diseases, with results expected soon.
For further insights into AU:1AI stock, check out TipRanks’ Stock Analysis page.
